|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
ES2211151T3
(es)
|
1998-08-19 |
2004-07-01 |
Skyepharma Canada Inc. |
Dispersiones acuosas inyectables de propofol.
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
EP1490030B2
(en)
*
|
2002-03-20 |
2010-07-14 |
Elan Pharma International Limited |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
JP2006504771A
(ja)
*
|
2002-10-29 |
2006-02-09 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
システインを伴うプロポフォール
|
|
JP2006524632A
(ja)
|
2002-12-09 |
2006-11-02 |
アメリカン バイオサイエンス、インコーポレイテッド |
組成物及び薬物送達方法
|
|
US7468394B1
(en)
*
|
2003-03-11 |
2008-12-23 |
Amphastar Pharmaceuticals, Inc. |
Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation
|
|
US20040225022A1
(en)
*
|
2003-05-09 |
2004-11-11 |
Desai Neil P. |
Propofol formulation containing reduced oil and surfactants
|
|
US8476010B2
(en)
*
|
2003-07-10 |
2013-07-02 |
App Pharmaceuticals Llc |
Propofol formulations with non-reactive container closures
|
|
US8546453B2
(en)
|
2003-08-14 |
2013-10-01 |
Rensheng Zhang |
Propofol compositions and methods for reducing pain associated with propofol injection
|
|
RU2290169C1
(ru)
*
|
2005-06-23 |
2006-12-27 |
Открытое Акционерное Общество "Фаберлик" |
Косметическое и/или дерматологическое средство и антиоксидант
|
|
TR200801336T1
(tr)
|
2005-08-31 |
2008-08-21 |
Abraxis Bioscience, Inc. |
Kararlılığı artmış zayıf su çöznurluğune sahip ilaçların preparasyonuna yönelik kompozisyonlar ve yöntemler.
|
|
KR101457834B1
(ko)
*
|
2005-08-31 |
2014-11-05 |
아브락시스 바이오사이언스, 엘엘씨 |
증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조 방법
|
|
CN101411685B
(zh)
*
|
2007-10-19 |
2011-04-20 |
上海医药工业研究院 |
一种静脉麻醉药2,6-二异丙基苯酚微乳组合物及其制备方法
|
|
KR101656121B1
(ko)
|
2010-03-17 |
2016-09-08 |
노바리크 게엠베하 |
안압 증가를 치료하기 위한 약학 조성물
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
BR112013016661B1
(pt)
*
|
2011-01-04 |
2021-08-03 |
Novaliq Gmbh |
Emulsões de o/a compreendendo alcanos semifluorados
|
|
BR112013022213A2
(pt)
*
|
2011-03-04 |
2017-05-02 |
Gruenenthal Gmbh |
administração parenteral de tapentadol
|
|
DK2680834T3
(en)
|
2011-03-04 |
2017-12-04 |
Gruenenthal Gmbh |
Semi-solid aqueous pharmaceutical composition containing tapentadol
|
|
JP2019142972A
(ja)
*
|
2011-03-04 |
2019-08-29 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
タペンタドールの非経口的投与
|
|
EP2680832B1
(en)
|
2011-03-04 |
2019-09-04 |
Grünenthal GmbH |
Aqueous pharmaceutical formulation of tapentadol for oral administration
|
|
EP2714010B1
(en)
|
2011-05-25 |
2017-03-01 |
Novaliq GmbH |
Topical pharmaceutical composition based on semifluorinated alkanes
|
|
JP2013001700A
(ja)
*
|
2011-06-21 |
2013-01-07 |
Fujifilm Corp |
プロポフォール含有水中油型エマルション組成物
|
|
JP5759804B2
(ja)
*
|
2011-06-27 |
2015-08-05 |
富士フイルム株式会社 |
容器詰製剤
|
|
DK2806886T3
(en)
|
2012-01-23 |
2017-06-06 |
Novaliq Gmbh |
STABILIZED PROTEIN COMPOSITIONS BASED ON SEMIFLUORED ALKANES
|
|
WO2013172999A1
(en)
|
2012-05-16 |
2013-11-21 |
Mewa Singh |
Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
|
|
EP3488847B1
(en)
|
2012-09-12 |
2023-11-08 |
Novaliq GmbH |
Semifluorinated alkane compositions
|
|
AU2013314370B2
(en)
|
2012-09-12 |
2017-11-30 |
Novaliq Gmbh |
Compositions comprising mixtures of semifluorinated alkanes
|
|
WO2015011199A1
(en)
|
2013-07-23 |
2015-01-29 |
Novaliq Gmbh |
Stabilized antibody compositions
|
|
BR112017018569A2
(pt)
|
2015-03-27 |
2018-04-24 |
Gruenenthal Gmbh |
formulação estável para administração parentérica de tapentadol
|
|
US10821087B2
(en)
*
|
2015-07-24 |
2020-11-03 |
Neon Laboratories Limited |
Stabilized injectable emulsion of Propofol and Ketamine
|
|
WO2017031261A1
(en)
|
2015-08-20 |
2017-02-23 |
Mewa Singh |
Polyphenolic polymer to make water-insoluble molecules become water-soluble
|
|
EP3495023B1
(en)
|
2015-09-30 |
2020-04-22 |
Novaliq GmbH |
Semifluorinated compounds and their compositions
|
|
KR102584063B1
(ko)
|
2015-09-30 |
2023-09-27 |
노바리크 게엠베하 |
부분불소화 화합물
|
|
USRE50060E1
(en)
|
2016-06-23 |
2024-07-30 |
Novaliq Gmbh |
Topical administration method
|
|
KR102614858B1
(ko)
|
2016-09-22 |
2023-12-18 |
노바리크 게엠베하 |
안검염 치료에 사용되는 약제학적 조성물
|
|
CA3036306C
(en)
|
2016-09-23 |
2024-05-14 |
Novaliq Gmbh |
Ophthalmic compositions comprising ciclosporin
|
|
WO2018055070A1
(en)
|
2016-09-23 |
2018-03-29 |
Grünenthal GmbH |
Stable formulation for parenteral administration of tapentadol
|
|
JP7032404B2
(ja)
|
2016-12-23 |
2022-03-08 |
ノバリック ゲーエムベーハー |
ドライアイ疾患の治療のための眼科用組成物
|
|
JP7072582B2
(ja)
|
2017-04-21 |
2022-05-20 |
ノバリック ゲーエムベーハー |
ヨウ素組成物
|
|
WO2018206656A1
(en)
|
2017-05-12 |
2018-11-15 |
Novaliq Gmbh |
Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
|
|
US11723861B2
(en)
|
2017-09-27 |
2023-08-15 |
Novaliq Gmbh |
Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
|
|
CN111182893A
(zh)
|
2017-10-04 |
2020-05-19 |
诺瓦利克有限责任公司 |
包含f6h8的眼用组合物
|
|
EP3758676A1
(en)
|
2018-03-02 |
2021-01-06 |
Novaliq GmbH |
Pharmaceutical compositions comprising nebivolol
|
|
JP2021522219A
(ja)
|
2018-04-27 |
2021-08-30 |
ノバリック ゲーエムベーハー |
緑内障の治療のためのタフルプロストを含む眼科用組成物
|
|
JP7500550B2
(ja)
|
2018-10-12 |
2024-06-17 |
ノバリック ゲーエムベーハー |
乾性眼疾患の治療のための眼科用組成物
|
|
WO2020165132A1
(en)
|
2019-02-13 |
2020-08-20 |
Novaliq Gmbh |
Compositions and methods for the treatment of ocular neovascularization
|